Heart Failure Drug Therapy in 2024: PSSNY Winter Conference
Target Audience
All pharmacists
Learning Objectives
Objectives:
▪Define the current types of heart failure according to ejection fraction
▪Describe current treatment options for patients various heart failure phenotypes with a focus on emerging treatments
▪Construct evidenced-based drug therapy regimens for patients with various heart failure phenotypes and comorbid conditions
Douglas Jennings, Pharm.D., FACC, FAHA, FCCP, FHFSA
Professor and Chair
Director, Advanced Heart Failure/Transplant Pharmacy Fellowship
Director, Assessment and Accreditation
Arnold & Marie Schwartz College of Pharmacy, Long Island University
Clinical Pharmacist, Heart Transplant and LVAD Team
NewYork-Presbyterian Hospital Columbia University Irving Medical Center
UAN# 0042-9999-24-063-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.